Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/13199
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-03-20T15:05:38Z-
dc.date.available2023-03-20T15:05:38Z-
dc.date.issued2008-02-
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/13199-
dc.publisherINCApt_BR
dc.subjectNeoplasias da Mama/tratamento farmacológicopt_BR
dc.subjectBreast Neoplasms/drug therapypt_BR
dc.subjectNeoplasias de la Mama/tratamiento farmacológicopt_BR
dc.subjectPreparações Farmacêuticaspt_BR
dc.subjectPharmaceutical Preparationspt_BR
dc.subjectPreparaciones Farmacéuticaspt_BR
dc.titleHC III participa de estudo internacionalpt_BR
dc.title.alternativeinformativo INCA 250pt_BR
dc.TypePeriodicalpt_BR
Appears in Collections:Informe INCA 250

Files in This Item:
File Description SizeFormat 
Informe INCA 250-4-HCIII-participa-de.pdf128.45 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.